Inhibition of CRMP2 Phosphorylation Suppresses Microglia Activation in the Retina and Optic Nerve and Promotes Optic Nerve Regeneration After Optic Nerve Injury
NeuroMolecular Medicine · 12.09.2024 · 26 (1)
DOI: 10.1007/s12017-024-08805-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, online erschienen am 12.09.2024. Verfasst von Yuebing Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science and Medical Bioscience, Waseda University, Shinjuku-ku, Tokyo, 162-8480, Japan. Hauptthemen laut MEDLINE: Optic Nerve Injuries, Microglia, Nerve Regeneration, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
As the primary connection between the eye and brain, the optic nerve plays a pivotal role in visual information transmission. Injuries to the optic nerve can occur for various reasons, including trauma, glaucoma, and neurodegenerative diseases. Retinal ganglion cells (RGCs), a type of neurons that extend axons through the optic nerve, can rapidly respond to injury and initiate cell death. Additionally, following optic nerve injury microglia, which serve as markers of neuroinflammation, transition from a resting state to an activated state. The phosphorylation of collapsin response mediator protein2 (CRMP2) in the semaphorin 3A (Sema3A) signalling pathway affects several processes, including axon guidance and neuron regeneration. In this study, we used an optic nerve crush (ONC) mouse model to investigate the effects of suppressing CRMP2 phosphorylation on microglia activation. We found that CRMP2 phosphorylation inhibitor suppressed RGCs loss and promoted neuronal regeneration following ONC. In addition, CRMP2 S522A mutant (CRMP2 KI) mice exhibited decreased microglial activation in both the retina and optic nerve following ONC. These results suggest that inhibiting the phosphorylation of CRMP2 can alleviate the loss of RGCs and microglial activation after optic nerve injury, providing insight into the development of treatments for optical neuropathies and neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science and Medical Bioscience, Waseda University, Shinjuku-ku, Tokyo, 162-8480, Japan.
- Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan.
- Department of Life Science and Medical Bioscience, Waseda University, Shinjuku-ku, Tokyo, 162-8480, Japan. ohshima@waseda.jp.
- Laboratory for Molecular Brain Science, Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo, 162-8480, Japan. ohshima@waseda.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Wang, Y., Harada, S., Goshima, Y., & Ohshima, T. (2024). Inhibition of CRMP2 Phosphorylation Suppresses Microglia Activation in the Retina and Optic Nerve and Promotes Optic Nerve Regeneration After Optic Nerve Injury. NeuroMolecular Medicine, 26(1). https://doi.org/10.1007/s12017-024-08805-1
Vancouver
Wang Y, Harada S, Goshima Y, Ohshima T. Inhibition of CRMP2 Phosphorylation Suppresses Microglia Activation in the Retina and Optic Nerve and Promotes Optic Nerve Regeneration After Optic Nerve Injury. NeuroMolecular Medicine. 2024;26(1). doi:10.1007/s12017-024-08805-1
BibTeX
@article{Wang2024,
author = {Wang, Yuebing and Harada, Sayaka and Goshima, Yoshio and Ohshima, Toshio},
title = {Inhibition of CRMP2 Phosphorylation Suppresses Microglia Activation in the Retina and Optic Nerve and Promotes Optic Nerve Regeneration After Optic Nerve Injury},
journal = {NeuroMolecular Medicine},
year = {2024},
volume = {26},
number = {1},
doi = {10.1007/s12017-024-08805-1}
}
EUVIMED